Counterfeiting, Compliance, and Controls

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Related Content:

Regulatory Oversight and ComplianceSupply ChainManufacturingPharmaceutical Technology-09-02-2003

Companies Reveal Their Next Moves in Manufacturing

Ushering in Industry 4.0 with the IDMO Model to Solve the CGT Manufacturing Bottleneck

Digital Transformation in Pharmaceutical Manufacturing